Skip to main content

Advertisement

SpringerLink
Log in

Serum lipid levels in benign prostatic hyperplasia

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

The relationship between serum lipid levels and measures of benign prostatic hyperplasia was investigated. The study was community based. All the participants had undergone a urological investigation which included International Prostate Symptom Score (I-PSS) and Quality of Life Score (QoL), serum lipid concentrations and determination of prostate volume with transrectal ultrasonography. Body mass index was calculated with the formula of weight (kg)/surface area (m2) respectively. Men were considered obese if their body mass index was over 25 kg/m2. BPH was defined by prostate volume greater than 20 ml and I-PSS greater than seven. Comparisons of serum lipid levels between men with BPH and without BPH were done. There was no correlation for serum lipid levels with either mean I-PSS and QoL scores. However, triglyceride and cholesterol levels were the lowest in severe symptomatic men than men with low symptoms. Using clinical definition of BPH that prostate volume was greater than 20 ml and I-PSS was greater than seven, men with BPH had not significantly different serum lipid levels from men without BPH. Our population-based data reflect that there was no relationship between serum lipid levels and certain physiological measures of lower urinary tract symptoms and clinical benign prostatic hyperplasia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Daniell HW (1993) Larger prostatic adenomas in obese men with no associated increase in obstructive uropathy. J Urol 149:315

    PubMed  CAS  Google Scholar 

  2. Glynn RJ, Campion EW, Bouchard GR, Silbert JE (1985) The development of benign prostatic hyperplasia among volunteers in the normative aging study. Am J Epidemiol 121:78

    PubMed  CAS  Google Scholar 

  3. Sidney S, Quesenberry C Jr, Sadler MC, Lydick EG, Guess HA, Cattolica EV (1991) Risk factors for surgically treated benign prostatic hyperplasia in a prepaid health care plan. Urology 38:13

    Article  PubMed  CAS  Google Scholar 

  4. Betteridge DJ, Morrell JM (1998) Risk assessment. In: Betteridge DJ, Morrell JM (eds) Lipids and coronary heart disease, 1st edn. Chapman & Hall, London, chap 6, pp 117–144

  5. Barry MJ (1990) Epidemiology and natural history of benign prostatic hyperplasia. Urol Clin North Am 17:495

    PubMed  CAS  Google Scholar 

  6. Lagiou P, Wuu J, Trichopoulou A, Hsiesh CC, Adamı HO, Trichopoulos D (1999) Diet and benign prostatic hyperplasia. A study in Greece. Urology 54(2):284

    Article  PubMed  CAS  Google Scholar 

  7. Myschetzky PS, Suburu RE, Kelly BS (1991) Determination of prostate gland volume by transrectal ultrasound: correlation with radical prostatectomy specimens. Scand J Urol Nephrol 137(suppl):107

    CAS  Google Scholar 

  8. Garraway WM, Collins GN, Lee RJ (1991) High prevalence of benign prostatic hyperplasia in the community. Lancet 338:469–471

    Article  PubMed  CAS  Google Scholar 

  9. Berry SJ, Coffey DS, Walsh PC, Ewing LL (1984) The development of human benign prostatic hyperplasia with age. J Urol 132:474

    PubMed  CAS  Google Scholar 

  10. McConnell JD (1998) Epidemiology, etiology, pathophysiology, and diagnosis of benign prostatic hyperplasia. Benign prostatic hyperplasia. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED (eds) Campbell’s urology, 7th edn. Saunders, Philadelphia, vol 2, pp 1429–1449

  11. Wattigney WA, Harsha DW, Srinivasan SR, Webber LS, Berenson GS (1991) Increasing impact of obesity on serum lipids and lipoproteins in young adults. The Bogalusa Heart Study. Arch Intern Med 151(10):2017–2222

    CAS  Google Scholar 

  12. Gotto AM, Carlson LA, Illingworth DR, Thompson GR (1996) Lipids and coronary heart disease risk. Quick reference to hyperlipidemia. In: Gotto AM (eds) Clinician’s manual on hyperlipidemia, 4th edn, chap 2. Science Press Limited, London, pp 13–15

  13. Geller RJ (1989) Overview of benign prostatic hypertrophy. Urology 34:57

    Article  PubMed  CAS  Google Scholar 

  14. Partin AW, Oesterling JE, Epstein JI, Horton R, Walsh PC (1993) Influence of age and endocrine factors on the volume of benign prostatic hyperplasia. J Urol 145:68

    Google Scholar 

  15. Zumoff B (1982) Relationship of obesity to blood estrogens. Cancer Res 42(suppl. 8):3289

    Google Scholar 

  16. Soygur T, Kupeli B, Aydos K, Kupeli S, Arikan N, Muftuoglu YZ (1996) Effect of obesity on prostatic hyperplasia: its relation to sex steroid levels. Int Urol Nephrol 28(1):55–59

    Article  PubMed  CAS  Google Scholar 

  17. Denti L, Pasolini G, Cortellini P, Sanfelici L, Benedetti R, Cecchetti A, Ferretti S, Bruschieri L, Ablondi F, Valenti G (2000) Changes in HDL-cholesterol and lipoprotein Lp(a) after 6-month treatment with finasteride in males affected by benign prostatic hyperplasia (BPH). Atherosclerosis 152(1):159–166

    Article  PubMed  CAS  Google Scholar 

  18. Boyle P, Liu GF, Jacobsen S et al (2000) Epidemiology and natural history. Benign prostatic hyperplasia. In: Chatelain C, Denis L, Foo KT et al (eds) Fifth international consultation on benign prostatic hyperplasia, Paris, pp 45–47

  19. Lee E, Park MS, Shin C, et al (1997) A high-risk group for prostatism: a population-based epidemiological study in Korea. Br J Urol 79(5):736–741

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Medical Faculty, Celal Bayar University, 45010, Manisa, Turkey

    Murat Lekili, Talha Müezzinoğlu & Coşkun Büyüksu

  2. Department of Biochemistry, Medical Faculty, Celal Bayar University, Manisa, Turkey

    Bekir Sami Uyanık

Authors
  1. Murat Lekili
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Talha Müezzinoğlu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bekir Sami Uyanık
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Coşkun Büyüksu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Murat Lekili.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lekili, M., Müezzinoğlu, T., Uyanık, B.S. et al. Serum lipid levels in benign prostatic hyperplasia. World J Urol 24, 210–213 (2006). https://doi.org/10.1007/s00345-006-0062-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-006-0062-6

Keywords

Search

Navigation